Subscribe to our insights here so you can keep on top of the latest IP developments and updates.
The General Court overturned an EUIPO revocation, holding that proof of genuine use must be assessed holistically. It rejected excessive evidential bu
Partners Dr Joanna Peak and Marcus Sims are attending The Pharma & Biotech Patent Litigation Summit Europe on 19-21 January in Amsterdam.
An analysis of how the EPO Boards of Appeal and the UPC Munich Local Division assessed inventive step for Sanofi’s cabazitaxel patent and why they r
A UK court confirmed Dryrobe’s trade marks remain valid, ruling that rival D-ROBE infringed them. The case highlights the need for brand owners to p
With the Grinch leading major UK Christmas ads, brands are leveraging character merchandising and tight IP licensing to stand out in a £12bn festive
WIPO’s updated Nice Classification, effective 1 Jan 2026, reclassifies eyewear, emergency vehicles, heated clothing and essential oils. Trademark ow
A look at the dispute between Sweaty Betty and Nixi Body over similar slogans and what it reveals about trade mark limits, descriptive branding and go
A guide to recording IP assignments worldwide, outlining key requirements, risks and best practices across the UK, EUIPO/EPC, Germany, Spain and the U
The CJEU clarifies that bad-faith trade mark filings face no time limits for invalidity actions, even when earlier owners knew of the bad faith or set
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
India has accepted its first smell trade mark for advertisement, a rose-scented tyre mark by Sumitomo. This milestone opens the door for broader prote
Boult’s Finance Director Anna shares insights on leading a growing team, embracing challenges, building confidence and enjoying a rewarding finance
Welcome to this series focusing on graduate careers in intellectual property (IP) and at Boult. If you’re considering a role in IP,
Angela Stephen is attending LSPN Europe in London on 1 December. The event will focus on end-to-end patent lifecycle management.
Boult has been included in Band 1 by Chambers and Partners UK for both Patents and Trade Marks in its 2026 ranking.
Alex Stephenson is attending the CIPA Life Sciences Conference in London on 20 November.
Dr Jonathan Palmer is attending APAA Malaysia 2025 on 6-10 November in Kuala Lumpur.
Partner Jo Peak and Senior Associate Farzana Miah are attending BIO-Europe 2025 in Vienna on 3-5 November.
Dr Olga Bohuszewicz is attending the 12th Lsbc Central European Life Science Investment Conference on 30-31 October.
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
Boult has been included in Band 1 by Chambers and Partners UK for both Patents and Trade Marks in its 2026 ranking.
Once again Boult is recognised as Tier 1 for both patents and trade marks in the Legal 500 UK rankings for 2026.
Boult has earned a Silver Medal from EcoVadis, the global sustainability ratings platform - recognising our commitment to ethical, responsible and environmentally conscious business practices.
Sign up to our insights so you can keep on top of the latest IP developments and updates.
SIGN UP
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
Boult has been included in Band 1 by Chambers and Partners UK for both Patents and Trade Marks in its 2026 ranking.
Once again Boult is recognised as Tier 1 for both patents and trade marks in the Legal 500 UK rankings for 2026.
Boult has earned a Silver Medal from EcoVadis, the global sustainability ratings platform - recognising our commitment to ethical, responsible and environmentally conscious business practices.
IPxNW is a leading networking event for professionals passionate about intellectual property across the North West — bringing together patent...
The Pharma & Biotech Patent Litigation Summit is a major European conference for life-sciences intellectual property professionals, focusing on patent...
LSPN Europe 2025 will focus on end-to-end patent lifecycle management, offering practical strategies for protecting and commercialising innovations in life...
The CIPA Life Sciences Conference is the leading UK event for IP professionals in the pharmaceutical, biotechnology and medical device...
APAA Malaysia 2025 will bring together IP professionals from across the Asia-Pacific region for a week of policy discussions, practical...
BIO-Europe 2025 is Europe’s premier annual partnering conference for the biotechnology, pharmaceutical and investment sectors. With over 5,000 attendees from...
The 12th Lsbc Central European Life Science Investment Conference top-level theme is: "The DNA of capital – Cracking the code...
Hosted jointly by the ABA Forum on the Entertainment & Sports Industries and the Section of Intellectual Property Law, this...
Organised by the Pharmaceutical Trademarks Group, this conference will bring together trademark professionals to discuss current challenges and opportunities in...
The Life Sciences Strategy Summit on IP & Exclusivity will convene legal and scientific experts to examine critical issues surrounding...
